tradingkey.logo

Biofrontera Inc

BFRI
0.821USD
-0.017-2.02%
종가 02/06, 16:00ET시세는 15분 지연됩니다
9.56M시가총액
손실P/E TTM

Biofrontera Inc

0.821
-0.017-2.02%

자세한 내용은 Biofrontera Inc 회사

Biofrontera Inc. is a biopharmaceutical company. The Company specializes in the development and commercialization of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy (PDT). The PDT treatment is used for the lesion-directed and field-directed treatment of actinic keratoses of mild-to-moderate severity on the face and scalp. The Company’s primary licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (the RhodoLED Lamps), are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions. The Company commercializes the drug-device combination Ameluz with the RhodoLED lamp series for PDT of AK, pre-cancerous skin lesions which may progress to invasive skin cancers. Its belixos ACTIVE CARE is a skin-soothing care foam for irritated and itchy skin, which can be used as basic care for atopic dermatitis and psoriasis as well as for soothing intensive care for everyday skin problems.

Biofrontera Inc 정보

종목 코드 BFRI
회사 이름Biofrontera Inc
상장일Oct 14, 2021
CEOLuebbert (Hermann)
직원 수92
유형Ordinary Share
회계 연도 종료Oct 14
주소120 Presidential Way,
도시WOBURN
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가United States of America
우편 번호01801
전화17812451325
웹사이트https://www.biofrontera-us.com/
종목 코드 BFRI
상장일Oct 14, 2021
CEOLuebbert (Hermann)

Biofrontera Inc의 회사 임원진

이름
이름/직위
직위
주식 보유
변동
Prof. Dr. Hermann Luebbert, Ph.D.
Prof. Dr. Hermann Luebbert, Ph.D.
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
152.71K
--
Mr. Eugene Frederick (Fred) Leffler, III
Mr. Eugene Frederick (Fred) Leffler, III
Chief Financial Officer
Chief Financial Officer
87.50K
--
Dr. John J. Borer, III
Dr. John J. Borer, III
Independent Director
Independent Director
--
--
Dr. Beth J. Hoffman, Ph.D.
Dr. Beth J. Hoffman, Ph.D.
Independent Director
Independent Director
--
--
Mr. Kevin D. Weber
Mr. Kevin D. Weber
Independent Director
Independent Director
--
--
Dr. Heikki Lanckriet, Ph.D.
Dr. Heikki Lanckriet, Ph.D.
Director
Director
--
--
Mr. George Jones
Mr. George Jones
Chief Commercial Officer
Chief Commercial Officer
--
--
이름
이름/직위
직위
주식 보유
변동
Prof. Dr. Hermann Luebbert, Ph.D.
Prof. Dr. Hermann Luebbert, Ph.D.
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
152.71K
--
Mr. Eugene Frederick (Fred) Leffler, III
Mr. Eugene Frederick (Fred) Leffler, III
Chief Financial Officer
Chief Financial Officer
87.50K
--
Dr. John J. Borer, III
Dr. John J. Borer, III
Independent Director
Independent Director
--
--
Dr. Beth J. Hoffman, Ph.D.
Dr. Beth J. Hoffman, Ph.D.
Independent Director
Independent Director
--
--
Mr. Kevin D. Weber
Mr. Kevin D. Weber
Independent Director
Independent Director
--
--
Dr. Heikki Lanckriet, Ph.D.
Dr. Heikki Lanckriet, Ph.D.
Director
Director
--
--

수익 분석

FY2024
FY2023
FY2022
FY2021
기업이 아직 관련 데이터를 공개하지 않았습니다.
지역별USD
이름
수익
비율
United States
37.32M
0.00%
사업별
지역별
기업이 아직 관련 데이터를 공개하지 않았습니다.

주식 보유 통계

마지막 업데이트: Sun, Feb 1
마지막 업데이트: Sun, Feb 1
주주
주주 유형
주주
주주
비율
Rosalind Advisors, Inc.
9.79%
AIGH Capital Management, LLC.
5.98%
Hewlett Fund, L.P.
4.05%
Biofrontera AG
3.43%
Lytton (Laurence W)
2.63%
기타
74.11%
주주
주주
비율
Rosalind Advisors, Inc.
9.79%
AIGH Capital Management, LLC.
5.98%
Hewlett Fund, L.P.
4.05%
Biofrontera AG
3.43%
Lytton (Laurence W)
2.63%
기타
74.11%
주주 유형
주주
비율
Hedge Fund
12.69%
Corporation
7.49%
Private Equity
6.49%
Individual Investor
4.70%
Investment Advisor/Hedge Fund
2.49%
Investment Advisor
1.74%
Venture Capital
0.15%
Research Firm
0.05%
기타
64.20%

기관 주식 보유

마지막 업데이트: Mon, Dec 8
마지막 업데이트: Mon, Dec 8
보고 기간
기관 수
보유 주식
비율
변동
2025Q4
34
2.85M
28.39%
--
2025Q3
35
2.85M
24.13%
+509.58K
2025Q2
38
2.48M
28.99%
+6.08K
2025Q1
43
1.91M
35.97%
-1.28M
2024Q4
42
2.24M
20.22%
+365.98K
2024Q3
37
1.95M
35.26%
+44.70K
2024Q2
40
1.95M
40.02%
-47.81K
2024Q1
39
1.85M
15.80%
+1.04M
2023Q4
36
279.45K
16.52%
+54.33K
2023Q3
39
75.19K
10.29%
-23.48K
더 보기

주주 활동

이름
보유 주식
비율
변동
Chg %
날짜
Rosalind Advisors, Inc.
644.39K
6.04%
--
--
Aug 13, 2025
AIGH Capital Management, LLC.
914.21K
8.57%
--
--
Aug 13, 2025
Hewlett Fund, L.P.
550.22K
5.16%
--
--
Aug 13, 2025
Biofrontera AG
400.00K
3.75%
--
--
Sep 16, 2025
Lytton (Laurence W)
306.70K
2.87%
-228.98K
-42.75%
Mar 31, 2025
Armistice Capital LLC
291.15K
2.73%
+141.15K
+94.10%
Sep 30, 2024
Worth Venture Partners, LLC
249.36K
2.34%
-125.08K
-33.41%
Jun 30, 2025
Luebbert (Hermann)
152.71K
1.43%
+137.50K
+903.95%
Sep 10, 2025
The Vanguard Group, Inc.
14.92K
0.14%
--
--
Aug 31, 2025
Leffler (Eugene Frederick)
87.50K
0.82%
+87.50K
--
Sep 10, 2025
더 보기

관련 ETF

이름
비율
데이터 없음

주식 배당금

지난 5년 동안 총 0.00 USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
데이터 없음

주식 분할

날짜
배당락일
유형
비율
Jul 03, 2023
Merger
20→1
Jul 03, 2023
Merger
20→1
Jul 03, 2023
Merger
20→1
Jul 03, 2023
Merger
20→1
날짜
배당락일
유형
비율
Jul 03, 2023
Merger
20→1
Jul 03, 2023
Merger
20→1
Jul 03, 2023
Merger
20→1
Jul 03, 2023
Merger
20→1
KeyAI